FIELD: medicine.
SUBSTANCE: pharmaceutical composition, suitable for application in treatment of ear diseases includes acceptable for ear thermoreversable water gel. Pharmaceutical composition consists of anti-inflammatory corticosteroid in form of multiple particles and polyoxypropylene and polyoxyethylene-based polymer. Composition is introduced locally to the subject, suffering from ear disease, by intratympanic introduction on membrane of cochlea window or near it.
EFFECT: composition in accordance with invention ensures prolonged release of anti-inflammatory corticosteroid through membrane of cochlea window into inner ear cochlea during, at least, 5 days after a single introduction.
12 cl, 9 dwg, 9 tbl, 31 ex
Title | Year | Author | Number |
---|---|---|---|
APOPTOSIS MODULATING COMPOSITIONS WITH CONTROLLED RELEASE AND METHODS OF TREATING EAR DISEASES | 2009 |
|
RU2493828C2 |
OTORHINOLOGICAL DELIVERING DEVICE | 2004 |
|
RU2334525C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING EAR DISEASES | 2009 |
|
RU2499592C2 |
CONTROL RELEASE ANTIMICROBIAL COMPOSITIONS FOR TREATING EAR DISEASES | 2009 |
|
RU2495662C2 |
THERAPEUTIC COMPOSITION FOR THE TREATMENT OF OTITIS MEDIA WITH PERFORATION OF THE TYMPANIC MEMBRANE | 2022 |
|
RU2782926C1 |
COMBINATIONS FOR TREATING IMMUNO-INFLAMMATORY DISORDERS | 2002 |
|
RU2322984C2 |
COMBINATIONS FOR TREATMENT OF INFLAMMATORY DISEASES | 2002 |
|
RU2300379C2 |
DISPERSIBLE PREPARATION OF ANTIINFLAMMATION AGENT | 2004 |
|
RU2319508C2 |
METHOD AND PHARMACEUTICAL COMPOSITION FOR ANTIPHLOGISTIC AGENT DELIVERY | 2004 |
|
RU2325189C2 |
PURIFIED DERIVATIVES OF SULFOALKYL ETHERS OF CYCLODEXTRINE OR THEIR MIXTURE, CLATRATE COMPLEX OF CYCLODEXTRINE DERIVATIVES WITH MEDICINAL, AND PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2113442C1 |
Authors
Dates
2012-12-20—Published
2009-05-14—Filed